https://www.mlo-online.com/disease/cancer/news/55398779/personalizing-metastatic-prostate-cancer-treatment-new-va-findings-and-rutgers-editorialMLO Onlineen2026-08-18T15:43:33.000ZPersonalizing metastatic prostate cancer treatment: New VA findings and Rutgers editorialhttps://www.mlo-online.com/management/careers/news/55398777/dr-erica-schwartz-is-now-cdc-directorMLO Onlineen2026-08-18T15:33:40.000ZDr. Erica Schwartz is now CDC directorhttps://www.mlo-online.com/molecular/news/55398770/idts-uncoverseq-sets-new-benchmark-for-crispr-off-target-detectionMLO Onlineen2026-08-18T15:25:59.000ZIDT's UNCOVERseq sets new benchmark for CRISPR off-target detectionhttps://www.mlo-online.com/disease/news/55398445/covid-19-and-viral-reactivation-insights-from-recent-studyMLO Onlineen2026-08-17T15:51:28.000ZCOVID-19 and viral reactivation: Insights from recent studyhttps://www.mlo-online.com/management/news/55398432/illinois-headquartered-healthcare-system-settles-potential-hipaa-violations-after-data-breachMLO Onlineen2026-08-17T15:34:44.000ZIllinois-headquartered healthcare system settles potential HIPAA violations after data breachhttps://www.mlo-online.com/information-technology/artificial-intelligence/news/55398424/first-patient-enrolled-in-arteras-direct-ai-study-to-assess-real-world-impact-of-ai-in-prostate-careMLO Onlineen2026-08-17T15:26:53.000ZFirst patient enrolled in Artera's DIRECT-AI study to assess real-world impact of AI in prostate carehttps://www.mlo-online.com/disease/antibiotic-resistance/news/55398416/calla-lily-clinical-care-to-join-wellcome-leaps-focused-antibiotics-program-to-address-amrMLO Onlineen2026-08-17T15:17:01.000ZCalla Lily Clinical Care to join Wellcome Leap’s Focused Antibiotics Program to address AMR